We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Injectable Spacer Preserves Bowels During Prostate Radiotherapy

By MedImaging International staff writers
Posted on 20 Oct 2016
Print article
Image: The SpaceOAR system benefits (Photo courtesy of Augmenix).
Image: The SpaceOAR system benefits (Photo courtesy of Augmenix).
A novel hydrogel rectal spacer used during radiotherapy (RT) for prostate cancer results in significantly less rectal toxicity and urinary incontinence, according to a new study.

Researchers at Texas Oncology (Irving, USA) reported the three-year follow-up results from a phase III trial in patients with low-intermediate risk prostate cancer who were injected with the SpaceOAR, an absorbable hydrogel rectal spacer that separates the rectum from the prostate during RT to potentially reduce the risk of adjacent organ-at-risk (OAR) injury. The researchers examined the cumulative incidence of toxicity and mean changes in quality of life (QoL) summary scores, based on previously established thresholds.

Three-year results showed that grade 1+ rectal toxicity incidence in patients with the SpaceOAR was just 2%, compared with 90% in controls. Incidence of grade 2+ rectal toxicity was 6% in the controls, with no cases of grade 2+ toxicity reported in those receiving SpaceOAR spacer. Grade 1+ urinary incontinence was lower in patients with the spacer (4%) than in controls (15%), but there was no difference in grade 2+ urinary effects between groups. The study was presented at the annual meeting of the American Society for Radiation Oncology (ASTRO), held during September 2016 in Boston (MA, USA).

“The distance between the prostate and rectum is typically 1-2 mm; a trans-perineal procedure can be used to place the hydrogel device between the prostate and the rectum, increasing the distance to approximately 1 cm, thus putting the rectum out of harm's way during radiotherapy,” said lead author and study presenter Daniel Hamstra, MD, PhD. “Rectal dosimetry was tremendously better after placement of the hydrogel spacer, and what this correlated with was a decrease in rectal toxicity. We saw significant and dramatic relative reductions of rectal dosimetry at all levels assessed.”

The SpaceOAR system, a product of Augmenix (Waltham, MA, USA), is a temporary hydrogel injected through the perineum, guided by transrectal ultrasound. The material flows into the space between the prostate and the rectum and expands within ten seconds, reducing rectum radiation during prostate RT. Shielding the rectum also permits dose escalation and hypo-fractionation, resulting in more prostate radiation, improved cancer kill rates, and fewer radiation treatment sessions. The hydrogel remains in place for three months and is then liquefied and absorbed, leaving nothing behind.

Related Links:
Texas Oncology
Augmenix
Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Digital Radiography Acquisition Software
VXvue with PureImpact
New
Ultrasound Doppler System
Doppler BT-200
New
Digital Radiography Generator
meX+20BT lite

Print article

Channels

Radiography

view channel
:	Image: The AI model could be a valuable adjunct to human radiologists in breast cancer diagnoses and risk prediction (Photo courtesy of 123RF)

AI Model Predicts 5-Year Breast Cancer Risk from Mammograms

Approximately 13% of U.S. women, or one in every eight, are predicted to develop invasive breast cancer over their lifetime, with 1 in 39 women (3%) succumbing to the illness, according to the American... Read more

General/Advanced Imaging

view channel
Image: The CIARTIC Move self-driving mobile C-arm has received FDA clearance (Photo courtesy of Siemens)

Self-Driving Mobile C-Arm Reduces Imaging Time during Surgery

Intraoperative imaging faces significant challenges due to staff shortages and the high demands placed on surgical teams in the operating room (OR). A common challenge during many OR procedures is the... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: Samsung Medison CEO Mr. Yongkwan Kim and Bracco Imaging CEO Dr. Fulvio Renoldi Bracco endorsed a MoU agreement (Photo courtesy of Bracco Group)

Samsung and Bracco Enter Into New Diagnostic Ultrasound Technology Agreement

Samsung Medison (Seoul, South Korea) and Bracco Imaging (Milan, Italy) have entered into a Memorandum of Understanding (MoU) agreement to pioneer a new area for diagnostic ultrasound devices and contrast agents.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.